Sandro Barni

23.3k total citations · 4 hit papers
479 papers, 14.5k citations indexed

About

Sandro Barni is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Sandro Barni has authored 479 papers receiving a total of 14.5k indexed citations (citations by other indexed papers that have themselves been cited), including 275 papers in Oncology, 167 papers in Pulmonary and Respiratory Medicine and 75 papers in Cancer Research. Recurrent topics in Sandro Barni's work include Cancer Treatment and Pharmacology (89 papers), Colorectal Cancer Treatments and Studies (84 papers) and Circadian rhythm and melatonin (58 papers). Sandro Barni is often cited by papers focused on Cancer Treatment and Pharmacology (89 papers), Colorectal Cancer Treatments and Studies (84 papers) and Circadian rhythm and melatonin (58 papers). Sandro Barni collaborates with scholars based in Italy, United States and Switzerland. Sandro Barni's co-authors include Fausto Petrelli, Mary Cabiddu, Karen Borgonovo, Gabriele Tancini, Paolo Lissoni, Mara Ghilardi, Andrea Coinu, Veronica Lonati, Roberto Labianca and Michele Ghidini and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and JNCI Journal of the National Cancer Institute.

In The Last Decade

Sandro Barni

471 papers receiving 14.1k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prognostic Survival Associated With Left-Sided vs Right-Sided Colon Cancer

2016 511 citations Fausto Petrelli, Gianluca Tomasello et al. profile →
Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: a randomised, placebo-controlled, double-blind study

2009 446 citations Mario Mandalà, Luigi Cavanna et al. profile →
Predictive role of BRAF mutations in patients with advanced colorectal cancer receiving cetuximab and panitumumab: A meta-analysis

2015 350 citations Fausto Petrelli, Karen Borgonovo et al. European Journal of Cancer profile →
Association of Obesity With Survival Outcomes in Patients With Cancer

2021 302 citations Fausto Petrelli, Gianluca Tomasello et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Sandro Barni	7.7k	4.3k	2.6k	2.0k	1.9k	479	14.5k
Pär Stattin	5.0k 0.7×	7.0k 1.6×	2.1k 0.8×	3.6k 1.7×	4.9k 2.6×	419	16.8k
Kathleen I. Pritchard	15.6k 2.0×	5.4k 1.2×	1.2k 0.5×	9.9k 4.9×	6.1k 3.2×	369	25.4k
Pamela J. Goodwin	6.9k 0.9×	1.8k 0.4×	1.1k 0.4×	2.7k 1.3×	4.9k 2.6×	172	12.2k
Shaker R. Dakhil	9.2k 1.2×	5.1k 1.2×	1.4k 0.5×	3.1k 1.5×	3.3k 1.7×	313	16.4k
Fabrizio Veglia	2.0k 0.3×	2.3k 0.5×	2.5k 1.0×	585 0.3×	1.6k 0.9×	291	14.5k
Joseph P. Costantino	11.4k 1.5×	3.3k 0.8×	2.9k 1.1×	12.3k 6.1×	2.9k 1.5×	200	24.3k
Javid J. Moslehi	6.6k 0.9×	2.2k 0.5×	1.2k 0.5×	1.3k 0.6×	3.7k 1.9×	211	16.0k
Allan Tsung	4.4k 0.6×	2.5k 0.6×	4.5k 1.7×	1.5k 0.8×	4.2k 2.2×	342	18.1k
John Horton	6.9k 0.9×	5.2k 1.2×	2.8k 1.1×	1.3k 0.6×	1.6k 0.8×	104	16.7k
Robert Makuch	2.7k 0.3×	3.3k 0.8×	2.5k 1.0×	525 0.3×	1.9k 1.0×	206	16.6k

Countries citing papers authored by Sandro Barni

Since Specialization

Citations

This map shows the geographic impact of Sandro Barni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandro Barni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandro Barni more than expected).

Fields of papers citing papers by Sandro Barni

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandro Barni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandro Barni. The network helps show where Sandro Barni may publish in the future.

Co-authorship network of co-authors of Sandro Barni

This figure shows the co-authorship network connecting the top 25 collaborators of Sandro Barni. A scholar is included among the top collaborators of Sandro Barni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandro Barni. Sandro Barni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cuomo, Arturo, Marco Cascella, Cira Antonietta Forte, et al.. (2020). Careful Breakthrough Cancer Pain Treatment through Rapid-Onset Transmucosal Fentanyl Improves the Quality of Life in Cancer Patients: Results from the BEST Multicenter Study. Journal of Clinical Medicine. 9(4). 1003–1003. 34 indexed citations

Inno, Alessandro, Sandro Barni, Antonio Ghidini, Alberto Zaniboni, & Fausto Petrelli. (2018). One year versus a shorter duration of adjuvant trastuzumab for HER2-positive early breast cancer: a systematic review and meta-analysis. Breast Cancer Research and Treatment. 173(2). 247–254. 24 indexed citations

Petrelli, Fausto, Michele Ghidini, Veronica Lonati, et al.. (2017). The efficacy of lapatinib and capecitabine in HER-2 positive breast cancer with brain metastases: A systematic review and pooled analysis. European Journal of Cancer. 84. 141–148. 89 indexed citations

Petrelli, Fausto, Gianluca Tomasello, Sandro Barni, et al.. (2017). Clinical and pathological characterization of HER2 mutations in human breast cancer: a systematic review of the literature. Breast Cancer Research and Treatment. 166(2). 339–349. 62 indexed citations

Petrelli, Fausto, Serena Di Cosimo, Veronica Lonati, & Sandro Barni. (2016). Vinorelbine With Capecitabine, an Evergreen Doublet for Advanced Breast Cancer: A Systematic Literature Review and Pooled-Analysis of Phase II-III Studies. Clinical Breast Cancer. 16(5). 327–334. 15 indexed citations

Tucci, Marcello, Orazio Caffo, Massimo Di Maïo, et al.. (2016). Prognostic role of body mass index (BMI) in patients with metastatic castration resistant prostate cancer (mCRPC) receiving chemotherapy: PRO-BMI study. Annals of Oncology. 27. iv34–iv34. 1 indexed citations

Personeni, Nicola, Lorenza Rimassa, Claudio Verusio, et al.. (2015). FOLFIRI and Cetuximab Every Second Week for First-Line Treatment of KRAS Wild-Type Metastatic Colorectal Cancer According to Phosphatase and Tensin Homolog Expression: A Phase II Study. Clinical Colorectal Cancer. 14(3). 162–169. 9 indexed citations

Markopoulos, Christos, Patrick Neven, Minna Tanner, et al.. (2015). Does patient education work in breast cancer? Final results from the global CARIATIDE study. Future Oncology. 11(2). 205–217. 21 indexed citations

Orlando, Laura, Francesco Giotta, Vito Lorusso, et al.. (2014). Biweekly Combination of Trastuzumab, Docetaxel and Gemcitabine for HER2-Positive Metastatic Breast Cancer: Results of a Phase II GOIM Study. Future Oncology. 10(5). 725–733. 3 indexed citations

10.

Barni, Sandro, et al.. (2014). Brio: A European Prospective Observational Study to Assess the Burden of Disease and Treatment in Metastatic Breast Cancer (Mbc) Patients Treated with Oral Vinorelbine (Nvboral) or Intravenous Vinorelbine (Ivvino). Value in Health. 17(7). A647–A647. 1 indexed citations

11.

Simoni, L., et al.. (2014). An Italian Oncology Research to Evaluate Adherence to Clinical Guidelines for Cancer Treatment: The Right Program. Value in Health. 17(7). A653–A653. 1 indexed citations

12.

Tarantini, Luigi, Pompilio Faggiano, Sandro Barni, & Stefania Gori. (2013). Monitoraggio del danno cardiaco nel paziente oncologico in trattamento con farmaci cardiotossici. Giornale italiano di cardiologia. 14(6). 416–23. 1 indexed citations

13.

Petrelli, Fausto & Sandro Barni. (2012). Role of HER2-neu as a prognostic factor for survival and relapse in pT1a–bN0M0 breast cancer: a systematic review of the literature with a pooled-analysis. Medical Oncology. 29(4). 2586–2593. 33 indexed citations

14.

James, R.D., Sandro Barni, Ludwig Fischer von Weikersthal, et al.. (2010). Improving chemotherapy capacity by switching from i.v. to oral vinorelbine. University of Southern Denmark Research Portal (University of Southern Denmark). 4. 14–18. 5 indexed citations

15.

Robertson, J.F.R., Guenther G. Steger, P. Neven, et al.. (2009). Activity of fulvestrant in HER2-overexpressing advanced breast cancer. Annals of Oncology. 21(6). 1246–1253. 20 indexed citations

16.

Mandalà, Mario, Sandro Barni, Martin H. Prins, et al.. (2009). Acquired and inherited risk factors for developing venous thromboembolism in cancer patients receiving adjuvant chemotherapy: a prospective trial. Annals of Oncology. 21(4). 871–876. 79 indexed citations

17.

Lissoni, Paolo, Sandro Barni, Mario Mandalà, et al.. (1998). Immunobiological effects of interleukin-2, interleukin-12 or interleukin-2 plus interleukin-12 in metastatic cancer patients. 14(1). 41–44. 1 indexed citations

18.

Lissoni, Paolo, Sandro Barni, Fernando Brivio, et al.. (1995). A Biological Study on the Efficacy of Low–Dose Subcutaneous lnterleukin–2 plus Melatonin in the Treatment of Cancer–Related Thrombocytopenia. Oncology. 52(5). 360–362. 26 indexed citations

19.

Gasparini, Giulio, Orazio Caffo, Sandro Barni, et al.. (1994). Vinorelbine is an active antiproliferative agent in pretreated advanced breast cancer patients: a phase II study.. Journal of Clinical Oncology. 12(10). 2094–2101. 133 indexed citations

20.

Barni, Sandro, et al.. (1984). Cytochemistry of cell surface sialoglycoconjugates in endometrial adenocarcinoma. Effects of medroxyprogesterone therapy.. PubMed. 2(3). 135–45. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact